SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-24-023593
Filing Date
2024-03-18
Accepted
2024-03-18 17:18:47
Documents
96
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 20-F ea0201881-20fa1_clear.htm   iXBRL 20-F/A 872384
2 CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., A FIRM IN THE DELOITTE GLOBAL NETWORK, ea020188101ex15-1_clearmind.htm EX-15.1 2166
3 CONSENT OF SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP ea020188101ex15-2_clearmind.htm EX-15.2 2700
4 GRAPHIC image_001.jpg GRAPHIC 4512
5 GRAPHIC image_002.jpg GRAPHIC 11122
6 GRAPHIC ex15-2_001.jpg GRAPHIC 22390
  Complete submission text file 0001213900-24-023593.txt   6378018

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cmnd-20231031.xsd EX-101.SCH 126053
8 XBRL CALCULATION FILE cmnd-20231031_cal.xml EX-101.CAL 44103
9 XBRL DEFINITION FILE cmnd-20231031_def.xml EX-101.DEF 335679
10 XBRL LABEL FILE cmnd-20231031_lab.xml EX-101.LAB 731972
11 XBRL PRESENTATION FILE cmnd-20231031_pre.xml EX-101.PRE 359880
100 EXTRACTED XBRL INSTANCE DOCUMENT ea0201881-20fa1_clear_htm.xml XML 856180
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 20-F/A | Act: 34 | File No.: 001-41557 | Film No.: 24760110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)